S-1 (tegafur/gimeracil/oteracil)对晚期胃癌患者的经济评估和预算影响分析

{"title":"S-1 (tegafur/gimeracil/oteracil)对晚期胃癌患者的经济评估和预算影响分析","authors":"M. Ruggeri, S. Coretti, A. Carletto, M. Marchetti, A. Sgambato","doi":"10.1007/S40276-013-0007-1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":187376,"journal":{"name":"PharmacoEconomics Italian Research Articles","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Valutazione economica e analisi di budget impact di S-1 (tegafur/gimeracil/oteracil) in pazienti con carcinoma gastrico avanzato\",\"authors\":\"M. Ruggeri, S. Coretti, A. Carletto, M. Marchetti, A. Sgambato\",\"doi\":\"10.1007/S40276-013-0007-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":187376,\"journal\":{\"name\":\"PharmacoEconomics Italian Research Articles\",\"volume\":\"61 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PharmacoEconomics Italian Research Articles\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/S40276-013-0007-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Italian Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/S40276-013-0007-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}